- Home
- HKD vs BNTC Comparison
HKD vs BNTC Comparison
Compare HKD & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HKD | BNTC |
|---|---|---|
| Founded | 2003 | 1995 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 408.6M | 405.7M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | HKD | BNTC |
|---|---|---|
| Price | $1.40 | $12.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $27.67 |
| AVG Volume (30 Days) | ★ 293.0K | 203.1K |
| Earning Date | 02-27-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $87,436,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.02 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.26 | $9.70 |
| 52 Week High | $5.47 | $17.15 |
Technical Indicators
Market Signals| Indicator | HKD | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 49.77 | 46.44 |
| Support Level | $1.38 | $11.40 |
| Resistance Level | $1.45 | $12.55 |
| Average True Range (ATR) | 0.05 | 0.85 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 81.58 | 32.08 |
Price Performance
Historical ComparisonAbout HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.